FIELD: medicine.
SUBSTANCE: invention refers to drugs and concerns application of N-(2-arylpropionyl) sulphonamides of general formula 
wherein R', R2 and R have the values specified in the formula, for preparing a drug for treating spinal cord injures. Offered N-(2-arylpropionyl) sulphonamides of general formula (I) provide blocking of oligodendrocyte apoptosis and maintains glia tissue of spinal cord.
EFFECT: preparation of the drug for treating spinal cord injures.
3 cl, 4 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| EGF/GHRP-6 COMBINATION FOR CENTRAL NERVOUS SYSTEM NEUROREGENERATION AFTER AUTOIMMUNNE DAMAGE | 2006 |
|
RU2403913C2 |
| N-(2-ARYLPROPIONYL)SULFONAMIDES AND PHARMACEUTICAL PREPARATION COMPRISING THEREOF | 1999 |
|
RU2255084C2 |
| 2-PHENYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2005 |
|
RU2375347C2 |
| SULFONIC ACIDS, DERIVATIVES OF SAID ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2004 |
|
RU2345063C2 |
| METHOD FOR MODELING A SPINAL CORD INJURY WITH PERSISTENT NEUROLOGICAL DEFICIT | 2021 |
|
RU2763666C1 |
| COMPOSITION FOR THERAPY, DELAY OR PREVENTION OF DEMENTIA, BRAIN AGEING, COGNITIVE DETERIORATION, APOPLECTIC ATTACK OR ALZHEIMER DESEASE WITH ANIMALS AND USAGE OF COMPOSITION (VERSIONS) | 2006 |
|
RU2400102C2 |
| NEW APPLICATION | 2004 |
|
RU2416426C2 |
| METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS | 2003 |
|
RU2353385C2 |
| ERYTHROPOIETIN APPLICATION FOR POSTINSULT REHABILITATION | 2004 |
|
RU2341284C2 |
| APPLYING (R)-IBUPROFEN METHANESULFONAMIDE AND ITS SALTS FOR TREATMENT AND PROPHYLAXIS OF REJECTION RESPONSE OF TRANSPLANTABLE ORGANS | 2002 |
|
RU2257895C2 |
